NCT06881810View on ClinicalTrials.gov

Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment

PHASE2RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

August 29, 2024

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
Schizophrenia Spectrum Disorders (SSD)
Interventions
DRUG

Oxytocin nasal spray

Syntocinon® nasal spray is applied according to description in arms section

OTHER

Placebo

Placebo nasal spray is applied according to description in arms section

Trial Locations (1)

68159

RECRUITING

Central Institute of Mental Health, Department of Psychiatry,, Mannheim

All Listed Sponsors
lead

Central Institute of Mental Health, Mannheim

OTHER